Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network

James D. Chalmers (Lead / Corresponding author), Felix C. Ringshausen, Bridget Harris, J. Stuart Elborn, Annette Posthumus, Charles S. Haworth, Nicola Pilkington, Eva Polverino, Thomas Ruddy, Stefano Aliberti, Pieter C. Goeminne, Craig Winstanley, Anthony De Soyza

Research output: Contribution to journalArticle

12 Citations (Scopus)
100 Downloads (Pure)

Abstract

There is a small risk of cross infection with Pseudomonas aeruginosa in bronchiectasis, but the benefit of specialised clinics, chest physiotherapy and pulmonary rehabilitation outweigh theoretical risks.
Original languageEnglish
Article number1701937
Number of pages6
JournalEuropean Respiratory Journal
Volume51
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Fingerprint Dive into the research topics of 'Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network'. Together they form a unique fingerprint.

  • Cite this

    Chalmers, J. D., Ringshausen, F. C., Harris, B., Elborn, J. S., Posthumus, A., Haworth, C. S., Pilkington, N., Polverino, E., Ruddy, T., Aliberti, S., Goeminne, P. C., Winstanley, C., & De Soyza, A. (2018). Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network. European Respiratory Journal, 51(1), [1701937]. https://doi.org/10.1183/13993003.01937-2017